Citation Impact
Citing Papers
MicroRNAs Reprogram Normal Fibroblasts into Cancer-Associated Fibroblasts in Ovarian Cancer
2012
Microtubule-Depolymerizing Agents Used in Antibody–Drug Conjugates Induce Antitumor Immunity by Stimulation of Dendritic Cells
2014
Trastuzumab emtansine (T-DM1) renders HER2 + breast cancer highly susceptible to CTLA-4/PD-1 blockade
2015
Markers Distinguishing Mesenchymal Stem Cells from Fibroblasts Are Downregulated with Passaging
2010
Inflammatory Cytokine-Induced Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Mesenchymal Stem Cells Are Critical for Immunosuppression
2010
Molecular cytogenetic characterization of Sézary syndrome
2003
Treatment of experimental arthritis by inducing immune tolerance with human adipose‐derived mesenchymal stem cells
2009
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice
2007
Sox9 Modulates Proliferation and Expression of Osteogenic Markers of Adipose-Derived Stem Cells (ASC)
2013 Standout
Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed–Sternberg cell
2007
Multicenter Photopheresis Intervention Trial in Early-Stage Mycosis Fungoides
2011
Hyaluronan–CD44 interactions as potential targets for cancer therapy
2011
Tumour-associated fibroblasts and mesenchymal stem cells: more similarities than differences
2010
Mechanisms of tumor escape from immune system: Role of mesenchymal stromal cells
2014
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers
2016
SOCS proteins, cytokine signalling and immune regulation
2007 Standout
TT Viruses: Oncogenic or Tumor-Suppressive Properties?
2008 StandoutNobel
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
High Clinical Response Rate of S ézary Syndrome to Immunomodulatory Therapies
2011
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease
2011 Standout
Mesenchymal stem cells in health and disease
2008 Standout
NF-κB, the first quarter-century: remarkable progress and outstanding questions
2012 Standout
Role of AID in Tumorigenesis
2007 StandoutNobel
Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy
2015
The Serine Protease Plasmin Triggers Expression of MCP-1 and CD40 in Human Primary Monocytes via Activation of p38 MAPK and Janus Kinase (JAK)/STAT Signaling Pathways
2002
The biology and function of fibroblasts in cancer
2016 Standout
Photopheresis in the treatment of cutaneous T-cell lymphoma
2011
The immune contexture in cancer prognosis and treatment
2017 Standout
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Mesenchymal stem cells: the fibroblasts' new clothes?
2008
Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)
2010
Stat proteins and oncogenesis
2002
Mitochondrial transfer from bone-marrow–derived stromal cells to pulmonary alveoli protects against acute lung injury
2012 Standout
Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sezary syndrome and mycosis fungoides
2002
TFOS DEWS II pathophysiology report
2017 Standout
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
What does Stat3 do?
2002 Standout
Extracorporeal Photopheresis in the Treatment of Mycosis Fungoides and Sézary Syndrome
2015
T Cells and Stromal Fibroblasts in Human Tumor Microenvironments Represent Potential Therapeutic Targets
2010
Extracorporeal photopheresis and liver transplantation: Our experience and preliminary data
2017
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
2004
Targeting of the innate immunity/inflammation as complementary anti-tumor therapies
2011
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
2011 Standout
Extracellular matrix structure
2015 Standout
Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes
2016
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Targeted therapy for Hodgkin lymphoma and systemic anaplastic large cell lymphoma: focus on brentuximab vedotin
2013
VTX-1463, a novel TLR8 agonist for the treatment of allergic rhinitis
2011
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma
2003
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD
2011
The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine
2013 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Epstein–Barr virus: 40 years on
2004 Standout
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Mechanisms of B-cell lymphoma pathogenesis
2005
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Blockage of the STAT3 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells
2008
Biology of Hodgkin's lymphoma
2002
Microenvironmental regulation of metastasis
2008 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
The STATs of cancer — new molecular targets come of age
2004 Standout
Reactive Astrocytes: Production, Function, and Therapeutic Potential
2017 Standout
BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription
2006
Contribution of the Epstein–Barr virus to the molecular pathogenesis of Hodgkin lymphoma
2007
Molecular biology of Hodgkin's lymphoma
2002
The AID Dilemma
2012 StandoutNobel
Idiopathic pulmonary fibrosis
2011 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Cancer and the chemokine network
2004 Standout
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
Part I: Hodgkin's lymphoma—molecular biology of Hodgkin and Reed-Sternberg cells
2003
Cancer-related inflammation and treatment effectiveness
2014 Standout
Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation
2006
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
2016 Standout
STAT Signaling in Cancer: Insights into Pathogenesis and Treatment Strategies
2006
Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer
2009 Standout
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Stem Cells and Cell Therapies in Lung Biology and Lung Diseases
2008
Curcumin: From ancient medicine to current clinical trials
2008 Standout
Targeting Signal‐Transducer‐and‐Activator‐of‐Transcription‐3 for Prevention and Therapy of Cancer
2006
STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells
2004
Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas
2007
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma
2009
Loss of the B-lineage–specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma
2003
Molecular Pathogenesis of Hodgkin's Lymphoma
2005
Acute Myeloid Leukemia
2015 Standout
Regulation and Function of NF-κB Transcription Factors in the Immune System
2009 Standout
Current approaches to prevent and treat GVHD after allogeneic stem cell transplantation
2018
Follicular Helper CD4 T Cells (TFH)
2011 Standout
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP
2006 Standout
The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
2007 Standout
Serine phosphorylation of STAT3 is essential for Mcl-1 expression and macrophage survival
2003
Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3α
2008
Mesenchymal Cells of the Intestinal Lamina Propria
2011
Erythrodermic mycosis fungoides and Sézary syndrome treated with extracorporeal photopheresis as part of a multimodality regimen: A single‐centre experience
2015
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Concise Review: The Surface Markers and Identity of Human Mesenchymal Stem Cells
2014
How I treat refractory and early relapsed acute myeloid leukemia
2015
Design, Synthesis, and Inhibitory Activity of Potent, Photoswitchable Mast Cell Activation Inhibitors
2013 StandoutNobel
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
The role of cytokines in classical Hodgkin lymphoma
2002
Stat proteins and oncogenesis
2002
How I treat mycosis fungoides and Sézary syndrome
2016
Macrophage plasticity and polarization in tissue repair and remodelling
2012 Standout
Type I IFN Activating Type I Dendritic Cells for Antitumor Immunity
2021
The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society
2017
Works of Udo Holtick being referenced
STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis
2005
Deregulation of immunoglobulin gene transcription in the Hodgkin–Reed Sternberg cell line L1236
2001
U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease
2008
Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours
2014
Meibography and meibomian gland measurements in ocular graft-versus-host disease
2015
Toll-like receptor 9 agonists as cancer therapeutics
2011
STAT3 is constitutively activated in Hodgkin cell lines
2001
Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults
2014
Brentuximab Vedotin Combined With Donor Lymphocyte Infusions for Early Relapse of Hodgkin Lymphoma After Allogeneic Stem-Cell Transplantation Induces Tumor-Specific Immunity and Sustained Clinical Remission
2012
2015
Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells.
2001
Adult Human Fibroblasts Are Potent Immunoregulatory Cells and Functionally Equivalent to Mesenchymal Stem Cells
2007